Glenda A Agustin, MD
Internal Medicine · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 12 years
- Graduated 2014
Offices
1 location · Blossom Ridge Medical Inc · 6 clinicians in this group
Hospitals listed: 059731 · 557690 · 559751 · 757092 · 757243 · B41714 · Oroville Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Agustin’s office at (916) 231-4747 to ask if they take your plan before you enroll.
California Medical Board record
Licence A176195 · Current
Licensed to practise in California · since 2022 · expires 2028-02-29 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Oroville HospitalOroville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of OroHealth CorporationPatients rate it 1 of 5 · 35% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Postoperative respiratory failure rate: 16.04 (9.53 to 22.55) · 404 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (11.1 to 19.4) · 136 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.262, Oct 2024 – Sep 2025
See every measure and the patient survey for Oroville Hospital
Behind the star rating — Deaths: 3 better, 4 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 6 the same, 4 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative respiratory failure rateComplications and deaths | 16.04 (9.53 to 22.55) · 404 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (11.1 to 19.4) · 136 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.07 (0.1 to 2.04) · 1,061 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.64 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 161.51 (102.1 to 220.92) · 64 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 5.3 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.6 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.6 · 205 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.8 · 749 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 19.1 · 141 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 1,984 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.33) · 7,583 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.12 to 0.5) · 7,702 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.75 (0.69 to 4.81) · 1,113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.44 (0 to 3.05) · 384 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.71 (0.23 to 3.2) · 1,061 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.47 (1.06 to 7.88) · 340 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 214 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.11 (0 to 0.69) · 4,910 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.497 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.451 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 39 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 26.7 · 239 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -24 · 54 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 66.7 · 254 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 60.8 · 898 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 25.5 · 851 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.4 (2.9 to 6.6) · 136 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7.8 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 22.8 · 96 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 17.9) · 1,050 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 285 cases | No different | Jan 2024 – Dec 2024 |
What patients said (769 patients answered, 12% of those asked)
| Cleanliness | 1 |
| Nurse communication | 1 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 1 |
| Overall hospital rating | 1 |
| Quietness | 1 |
| Recommend hospital | 1 |
| Room was "always" clean | 43% |
| Nurses "always" communicated well | 64% |
| Doctors "always" communicated well | 66% |
| Staff "always" explained | 45% |
| Yes, staff "did" give patients this information | 77% |
| Yes, staff "did" give patients information about help after discharge | 74% |
| Doctors "always" explained things so they could understand | 60% |
| Doctors "always" listened carefully | 63% |
| Doctors "always" treated them with courtesy and respect | 75% |
| Patients who gave a rating of "9" or "10" (high) | 35% |
| Staff "always" explained new medications | 57% |
| Nurses "always" explained things so they could understand | 59% |
| Nurses "always" listened carefully | 60% |
| Nurses "always" treated them with courtesy and respect | 73% |
| "Always" quiet at night | 29% |
| "YES", patients would definitely recommend the hospital | 35% |
| Staff "always" explained possible side effects | 33% |
| Yes, staff "did" give patients information about possible symptoms | 80% |
Original Medicare doctor bills
$7,768,461
Medicare paid this office $7,768,461 for 481 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Helicoll, per square centimeter | 13 | $3,223,273 | $1,162 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 330 | $103,469 | $51 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 14 | $24,404 | $126 |
| Long return visit (40+ min) | 95 | $22,348 | $136 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 103 | $16,408 | $76 |
See all 17 services
| Helicoll, per square centimeter | 13 | $3,223,273 | $1,162 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 330 | $103,469 | $51 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 14 | $24,404 | $126 |
| Long return visit (40+ min) | 95 | $22,348 | $136 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 103 | $16,408 | $76 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 60 | $12,721 | $39 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 110 | $11,169 | $40 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 179 | $8,759 | $44 |
| New patient visit (60+ min) | 38 | $6,601 | $174 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 30 | $6,136 | $40 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 220 | $4,997 | $11 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 87 | $4,881 | $34 |
| Return visit (30+ min) | 37 | $4,185 | $102 |
| Residence visit for established patient with low level of medical decision making, per day at least 30 minutes | 16 | $2,721 | $60 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 33 | $2,338 | $32 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 13 | $1,206 | $93 |
| Insertion of needle into vein for collection of blood sample | 18 | $103 | $5 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | – | – | – | – | 294 | 193 |
| Application of skin substitute graft to wound of trunk, arms, or legs, each additional 25.0 sq cm of wound 100.0 sq cm or less | – | – | – | – | 194 | – |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | – | – | – | – | 96 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
481 Original Medicare patients in 2024. Average age 76 · Under 65 11% · 85 and older 24% · Women 52% · Also on Medicaid 68% · Health risk score 2.43. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Dementia 46% · Depression 44% · Diabetes 42% · Chronic kidney disease 36% · Heart failure 35% · Coronary heart disease 33% · COPD 30% · Atrial fibrillation 30% · Stroke 20% · Cancer 11%.
The office billed $10,675,040, Medicare allowed $9,771,499 and paid $7,768,461; for 10,051 services of 55 kinds; $7,517,512 of it was for drugs given in the office and $250,949 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 481 | 10,051 | 76 | 2.43 | $10,675,040 | $7,768,461 |
| 2023 | 443 | 16,946 | 76 | 2.47 | $4,768,738 | $1,811,085 |
| 2022 | 317 | 3,773 | 75 | 2.58 | $752,852 | $308,711 |
| 2021 | 66 | 212 | 72 | 3.59 | $136,105 | $22,752 |
| 2020 | 121 | 376 | 70 | 3.79 | $209,156 | $38,484 |
| 2019 | 143 | 506 | 70 | 3.38 | $252,630 | $46,239 |
| 2018 | 65 | 274 | 71 | 3.47 | $125,510 | $24,422 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Puraply am, per square centimeter | 31 | $739,519 | $84 |
| Puraply xt, per square centimeter | 11 | $332,880 | $128 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 175 | $45,375 | $49 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 21 | $38,142 | $130 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 127 | $31,917 | $38 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 142 | $23,952 | $97 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 14 | $12,684 | $132 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 117 | $12,301 | $105 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 71 | $11,625 | $40 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 152 | $6,709 | $44 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 69 | $6,163 | $40 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 79 | $4,753 | $35 |
| Residence visit for established patient with low level of medical decision making, per day at least 30 minutes | 61 | $4,544 | $55 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 26 | $3,893 | $139 |
| Application of skin substitute graft to wound of trunk, arms, or legs, each additional 25.0 sq cm of wound 100.0 sq cm or less | 13 | $3,879 | $20 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 27 | $1,358 | $32 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 12 | $910 | $76 |
| Residence visit for new patient with low level of medical decision making, per day at least 30 minutes | 14 | $581 | $42 |
| Residence visit for established patient with straightforward medical decision making, per day at least 15 minutes | 11 | $523 | $37 |
| Administration of influenza virus vaccine | 12 | $392 | $33 |
| Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 20 | $272 | $11 |
| Insertion of needle into vein for collection of blood sample | 31 | $176 | $5 |
| Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 11 | $62 | $1 |
2022: 14 services
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 188 | $24,580 | $42 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 73 | $13,122 | $47 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 72 | $12,335 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $6,873 | $92 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 48 | $2,845 | $34 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 15 | $2,082 | $139 |
| New patient home visit, typically 45 minutes | 18 | $1,853 | $103 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 32 | $1,800 | $44 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 16 | $1,749 | $92 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 39 | $1,746 | $45 |
| Residence visit for established patient with low level of medical decision making, per day at least 30 minutes | 14 | $1,100 | $65 |
| Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | 11 | $1,020 | $78 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 18 | $902 | $35 |
| Insertion of needle into vein for collection of blood sample | 12 | $38 | $3 |
2021: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $12,394 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $6,015 | $182 |
| Hospital discharge day management, more than 30 minutes | 27 | $2,703 | $100 |
2020: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $20,891 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $8,579 | $172 |
| Hospital discharge day management, more than 30 minutes | 53 | $5,302 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,137 | $67 |
2019: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $15,332 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $13,348 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $9,263 | $94 |
| Hospital discharge day management, more than 30 minutes | 71 | $6,983 | $96 |
2018: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $10,275 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $7,218 | $185 |
| Hospital discharge day management, more than 30 minutes | 34 | $3,337 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,749 | $95 |
Medicaid work
$4,444 in 2024
Medicaid paid $4,444 for 1,054 billed services this clinician did in 2024, up to 102 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 676 | $2,189 |
| HOME/RES VISIT EST PATIENT MOD MDM 40 MINUTES | 72 | $1,104 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 73 | $593 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (List separately in addition to code for primary procedure) | 68 | $228 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 123 | $173 |
| Long return visit (40+ min) | 18 | $158 |
| Patient not eligible due to active diagnosis of hypertension | 24 | $0 |
| 2024 | 1,054 | 7 | 102 | $4,444 |
| 2023 | 797 | 4 | 39 | $6,130 |
| 2022 | 234 | 4 | 42 | $1,770 |
| 2021 | 122 | 2 | 19 | $10,433 |
| 2020 | 342 | 4 | 22 | $18,093 |
| 2019 | 35 | 2 | 12 | $2,803 |
| 2018 | 13 | 1 | 13 | $1,709 |
See the largest Medicaid services in earlier years
2023
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 356 | $2,517 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 331 | $2,332 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 97 | $1,281 |
| HOME/RES VISIT EST PATIENT MOD MDM 40 MINUTES | 13 | $0 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 50 | $1,552 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 121 | $188 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 34 | $17 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 29 | $13 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 95 | $7,471 |
| 1ST HOSP IP/OBS HIGH 75 | 27 | $2,962 |
2020
| 1ST HOSP IP/OBS HIGH 75 | 92 | $8,746 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 167 | $6,729 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 71 | $2,441 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 12 | $176 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 23 | $1,596 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 12 | $1,207 |
2018
| 1ST HOSP IP/OBS HIGH 75 | 13 | $1,709 |
Drugs they prescribed that Part D paid
$515,258
Pharmacies billed $515,258 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (202 of 7,817) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
7,115 generic and 659 brand-name prescriptions · $515,258 in drug cost · 96 antibiotic prescriptions to 50 people · 449 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 108 | $105,767 | $979 |
| Jardiance | 43 | $32,517 | $756 |
| Xarelto | 28 | $21,058 | $752 |
| Tradjenta | 19 | $10,383 | $546 |
| Ozempic | 11 | $9,549 | $868 |
See all 117 drugs
| Eliquis | 108 | $105,767 | $979 |
| Jardiance | 43 | $32,517 | $756 |
| Xarelto | 28 | $21,058 | $752 |
| Tradjenta | 19 | $10,383 | $546 |
| Ozempic | 11 | $9,549 | $868 |
| Januvia | 12 | $9,505 | $792 |
| Memantine | 123 | $8,435 | $69 |
| Myrbetriq | 15 | $7,326 | $488 |
| Entresto | 11 | $7,227 | $657 |
| Trelegy Ellipta | 11 | $7,102 | $646 |
| Breo Ellipta | 12 | $6,765 | $564 |
| Quetiapine | 205 | $5,988 | $29 |
| Gabapentin | 232 | $4,832 | $21 |
| Atorvastatin | 472 | $4,625 | $10 |
| Incruse Ellipta | 11 | $3,834 | $349 |
| Levetiracetam | 84 | $3,795 | $45 |
| Amlodipine Besylate | 386 | $3,612 | $9 |
| Sucralfate | 25 | $3,584 | $143 |
| Ondansetron Odt | 32 | $3,024 | $94 |
| Lidocaine | 17 | $2,849 | $168 |
| Pantoprazole | 198 | $2,823 | $14 |
| Mirtazapine | 112 | $2,822 | $25 |
| Levothyroxine | 238 | $2,754 | $12 |
| Lantus Solostar | 28 | $2,614 | $93 |
| Haloperidol | 65 | $2,513 | $39 |
| Olanzapine | 127 | $2,508 | $20 |
| Metoprolol | 145 | $2,424 | $17 |
| Trazodone | 222 | $2,357 | $11 |
| Levocarnitine | 14 | $2,286 | $163 |
| Pregabalin | 19 | $2,249 | $118 |
| Albuterol Sulfate Hfa | 71 | $2,187 | $31 |
| Divalproex | 116 | $2,133 | $18 |
| Novolog Flexpen | 20 | $1,997 | $100 |
| Donepezil | 110 | $1,849 | $17 |
| Aripiprazole | 27 | $1,832 | $68 |
| Citalopram Hbr | 54 | $1,770 | $33 |
| Hydrocodone-Acetaminophen | 83 | $1,750 | $21 |
| Risperidone | 70 | $1,747 | $25 |
| Lisinopril | 226 | $1,743 | $8 |
| Losartan | 147 | $1,695 | $12 |
| Tramadol | 75 | $1,675 | $22 |
| Escitalopram | 82 | $1,656 | $20 |
| Tamsulosin | 144 | $1,649 | $11 |
| Nano 2nd Gen Pen Needle | 19 | $1,618 | $85 |
| Omeprazole | 119 | $1,610 | $14 |
| Famotidine | 59 | $1,608 | $27 |
| Potassium Chloride | 60 | $1,531 | $26 |
| Rosuvastatin | 21 | $1,283 | $61 |
| Clopidogrel | 103 | $1,273 | $12 |
| Digoxin | 22 | $1,261 | $57 |
| Sertraline | 131 | $1,178 | $9 |
| Humalog Kwikpen U-100 | 13 | $1,156 | $89 |
| Furosemide | 254 | $1,143 | $5 |
| Duloxetine | 53 | $1,073 | $20 |
| Bupropion Xl | 30 | $1,020 | $34 |
| Nifedipine Er | 33 | $1,014 | $31 |
| Buspirone | 49 | $1,002 | $20 |
| Olanzapine Odt | 16 | $964 | $60 |
| Topiramate | 44 | $929 | $21 |
| Testosterone Cypionate | 30 | $856 | $29 |
| Lorazepam | 92 | $842 | $9 |
| Labetalol | 25 | $838 | $34 |
| Metformin | 122 | $826 | $7 |
| Loperamide | 18 | $800 | $44 |
| Memantine Hcl Er | 11 | $761 | $69 |
| Metoprolol | 105 | $759 | $7 |
| Finasteride | 46 | $752 | $16 |
| Hydroxychloroquine Sulfate | 11 | $742 | $67 |
| Divalproex Sodium Er | 28 | $708 | $25 |
| Simvastatin | 51 | $695 | $14 |
| Venlafaxine Hcl Er | 31 | $693 | $22 |
| Carvedilol | 61 | $687 | $11 |
| Fluoxetine | 28 | $598 | $21 |
| Hydroxyzine | 53 | $583 | $11 |
| Hydralazine | 43 | $561 | $13 |
| Triamcinolone Acetonide | 48 | $548 | $11 |
| Ondansetron | 26 | $542 | $21 |
| Azelastine | 15 | $506 | $34 |
| Benztropine Mesylate | 57 | $497 | $9 |
| Ketoconazole | 12 | $478 | $40 |
| Baclofen | 34 | $467 | $14 |
| Nystatin | 27 | $456 | $17 |
| Lactulose | 14 | $448 | $32 |
| Oxycodone-Acetaminophen | 13 | $437 | $34 |
| Glipizide Er | 39 | $429 | $11 |
| Atenolol | 43 | $422 | $10 |
| Ibuprofen | 30 | $419 | $14 |
| Metformin Hcl Er | 52 | $399 | $8 |
| Montelukast | 27 | $393 | $15 |
| Glipizide | 57 | $386 | $7 |
| Fludrocortisone Acetate | 18 | $379 | $21 |
| Latanoprost | 22 | $365 | $17 |
| Zolpidem | 14 | $350 | $25 |
| Fluticasone Propionate | 26 | $324 | $12 |
| Nitrofurantoin Mono-Macro | 38 | $320 | $8 |
| Diclofenac | 17 | $297 | $17 |
| Allopurinol | 30 | $284 | $9 |
| Propranolol | 26 | $279 | $11 |
| Oxycodone | 19 | $274 | $14 |
| Amiodarone | 11 | $269 | $24 |
| Spironolactone | 27 | $264 | $10 |
| Amantadine | 22 | $262 | $12 |
| Alendronate | 28 | $260 | $9 |
| Nortriptyline | 22 | $232 | $11 |
| Hydrochlorothiazide | 72 | $230 | $3 |
| Pioglitazone | 12 | $197 | $16 |
| Oxybutynin Chloride | 21 | $190 | $9 |
| Meclizine | 11 | $172 | $16 |
| Chlorhexidine Gluconate | 14 | $168 | $12 |
| Primidone | 15 | $128 | $9 |
| Alprazolam | 20 | $110 | $6 |
| Diazepam | 14 | $110 | $8 |
| Amoxicillin-Clavulanate Potass | 13 | $99 | $8 |
| Lamotrigine | 14 | $75 | $5 |
| Metoclopramide | 17 | $74 | $4 |
| Diltiazem 24hr Er (Cd) | 11 | $48 | $4 |
| Benazepril | 11 | $35 | $3 |
Year by year
| 2024 | 7,817 | 345 | 3% (202) | 8% | $515,258 |
| 2023 | 4,527 | 269 | 4% (160) | 9% | $391,181 |
| 2022 | 668 | 115 | 6% (37) | 13% | $67,813 |
| 2021 | 178 | 64 | None | None | $20,009 |
| 2020 | 214 | 88 | None | None | $18,112 |
| 2019 | 449 | 184 | None | None | $25,120 |
| 2018 | 589 | 100 | None | 17% | $48,445 |
| 2017 | 387 | 64 | None | None | $30,469 |
| 2016 | 383 | 97 | None | 29% | $37,324 |
| 2015 | 70 | 19 | 0% (0) | None | $11,638 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 91 drugs
| Eliquis | 67 | $82,134 | $1,226 |
| Lantus Solostar | 24 | $12,732 | $530 |
| Xarelto | 16 | $12,549 | $784 |
| Novolog Flexpen | 16 | $8,750 | $547 |
| Tradjenta | 13 | $7,538 | $580 |
| Jardiance | 11 | $6,250 | $568 |
| Lidocaine | 22 | $4,800 | $218 |
| Basaglar Kwikpen U-100 | 12 | $4,740 | $395 |
| Olanzapine | 108 | $4,436 | $41 |
| Gabapentin | 164 | $4,371 | $27 |
| Atorvastatin | 230 | $3,673 | $16 |
| Haloperidol | 58 | $3,094 | $53 |
| Hydrocodone-Acetaminophen | 64 | $2,871 | $45 |
| Memantine | 78 | $2,788 | $36 |
| Tamsulosin | 92 | $2,666 | $29 |
| Amlodipine Besylate | 203 | $2,510 | $12 |
| Divalproex | 78 | $2,374 | $30 |
| Quetiapine | 101 | $2,363 | $23 |
| Pantoprazole | 120 | $2,265 | $19 |
| Levothyroxine | 106 | $2,125 | $20 |
| Losartan | 105 | $1,895 | $18 |
| Trazodone | 128 | $1,540 | $12 |
| Albuterol Sulfate Hfa | 39 | $1,516 | $39 |
| Levetiracetam | 26 | $1,450 | $56 |
| Potassium Chloride | 56 | $1,400 | $25 |
| Pregabalin | 19 | $1,319 | $69 |
| Oxycodone-Acetaminophen | 24 | $1,247 | $52 |
| Omeprazole | 58 | $1,223 | $21 |
| Mirtazapine | 47 | $1,212 | $26 |
| Metoprolol | 51 | $1,206 | $24 |
| Escitalopram | 44 | $1,167 | $27 |
| Hydralazine | 35 | $1,088 | $31 |
| Ventolin Hfa | 18 | $1,072 | $60 |
| Propranolol | 27 | $1,058 | $39 |
| Lisinopril | 102 | $1,046 | $10 |
| Lorazepam | 72 | $1,012 | $14 |
| Metoprolol | 60 | $984 | $16 |
| Metformin | 66 | $956 | $14 |
| Duloxetine | 29 | $947 | $33 |
| Hydroxyzine | 38 | $904 | $24 |
| Furosemide | 148 | $904 | $6 |
| Famotidine | 50 | $881 | $18 |
| Ondansetron | 14 | $870 | $62 |
| Clozapine | 14 | $772 | $55 |
| Ibuprofen | 35 | $744 | $21 |
| Fluticasone Propionate | 30 | $738 | $25 |
| Nifedipine Er | 12 | $715 | $60 |
| Sertraline | 45 | $713 | $16 |
| Citalopram Hbr | 23 | $677 | $29 |
| Donepezil | 39 | $661 | $17 |
| Baclofen | 13 | $618 | $48 |
| Ondansetron Odt | 16 | $607 | $38 |
| Amantadine | 13 | $590 | $45 |
| Simvastatin | 43 | $585 | $14 |
| Finasteride | 34 | $584 | $17 |
| Buspirone | 15 | $567 | $38 |
| Clopidogrel | 26 | $565 | $22 |
| Brimonidine | 12 | $564 | $47 |
| Benztropine Mesylate | 24 | $546 | $23 |
| Tramadol | 41 | $539 | $13 |
| Labetalol | 20 | $526 | $26 |
| Oxycodone | 24 | $515 | $21 |
| Spironolactone | 17 | $509 | $30 |
| Venlafaxine | 21 | $433 | $21 |
| Amiodarone | 15 | $427 | $28 |
| Nitrofurantoin Mono-Macro | 33 | $423 | $13 |
| Topiramate | 17 | $421 | $25 |
| Carvedilol | 43 | $420 | $10 |
| Divalproex Sodium Er | 17 | $416 | $24 |
| Rosuvastatin | 16 | $415 | $26 |
| Fludrocortisone Acetate | 14 | $409 | $29 |
| Ropinirole | 13 | $358 | $28 |
| Alprazolam | 23 | $348 | $15 |
| Risperidone | 15 | $344 | $23 |
| Allopurinol | 15 | $336 | $22 |
| Hydrochlorothiazide | 43 | $296 | $7 |
| Venlafaxine Hcl Er | 23 | $276 | $12 |
| Pravastatin | 14 | $275 | $20 |
| Montelukast | 16 | $271 | $17 |
| Isosorbide Dinitrate | 28 | $263 | $9 |
| Clonazepam | 19 | $238 | $13 |
| Latanoprost | 12 | $234 | $19 |
| Triamcinolone Acetonide | 13 | $225 | $17 |
| Metformin Hcl Er | 16 | $224 | $14 |
| Alendronate | 12 | $210 | $17 |
| Glipizide | 26 | $170 | $7 |
| Metoclopramide | 13 | $161 | $12 |
| Prednisone | 20 | $109 | $5 |
| Cyclobenzaprine | 13 | $90 | $7 |
| Azithromycin | 16 | $82 | $5 |
| Sulfamethoxazole-Trimethoprim | 11 | $51 | $5 |
2022: 15 drugs
| Eliquis | 17 | $21,930 | $1,290 |
| Quetiapine | 16 | $662 | $41 |
| Hydrocodone-Acetaminophen | 14 | $542 | $39 |
| Pantoprazole | 24 | $495 | $21 |
| Gabapentin | 27 | $397 | $15 |
| Amlodipine Besylate | 24 | $307 | $13 |
| Famotidine | 19 | $250 | $13 |
| Atorvastatin | 16 | $247 | $15 |
| Losartan | 37 | $242 | $7 |
| Metoprolol | 16 | $231 | $14 |
| Metoprolol | 15 | $199 | $13 |
| Lorazepam | 19 | $156 | $8 |
| Furosemide | 20 | $124 | $6 |
| Tramadol | 12 | $106 | $9 |
| Isosorbide Dinitrate | 22 | $105 | $5 |
2021: 2 drugs
| Albuterol Sulfate Hfa | 17 | $552 | $32 |
| Nitroglycerin | 13 | $307 | $24 |
2020: 1 drug
| Albuterol Sulfate Hfa | 14 | $603 | $43 |
2019: 9 drugs
| Albuterol Sulfate Hfa | 26 | $1,293 | $50 |
| Nitroglycerin | 16 | $582 | $36 |
| Atorvastatin | 26 | $263 | $10 |
| Metoprolol | 14 | $178 | $13 |
| Pantoprazole | 20 | $173 | $9 |
| Furosemide | 19 | $76 | $4 |
| Amlodipine Besylate | 17 | $72 | $4 |
| Prednisone | 22 | $58 | $3 |
| Sulfamethoxazole-Trimethoprim | 11 | $25 | $2 |
2018: 17 drugs
| Novolog Flexpen | 12 | $6,419 | $535 |
| Symbicort | 11 | $5,194 | $472 |
| Lantus Solostar | 12 | $4,037 | $336 |
| Gabapentin | 26 | $319 | $12 |
| Atorvastatin | 47 | $318 | $7 |
| Metoprolol | 17 | $301 | $18 |
| Enalapril Maleate | 18 | $291 | $16 |
| Pantoprazole | 22 | $99 | $5 |
| Sertraline | 20 | $93 | $5 |
| Lisinopril | 33 | $78 | $2 |
| Carvedilol | 17 | $73 | $4 |
| Furosemide | 21 | $63 | $3 |
| Donepezil | 16 | $48 | $3 |
| Amlodipine Besylate | 14 | $45 | $3 |
| Metoprolol | 18 | $39 | $2 |
| Metformin | 11 | $28 | $3 |
| Hydrochlorothiazide | 11 | $9 | $1 |
2017: 8 drugs
| Enalapril Maleate | 21 | $260 | $12 |
| Metoprolol | 12 | $244 | $20 |
| Atorvastatin | 22 | $150 | $7 |
| Pantoprazole | 14 | $106 | $8 |
| Donepezil | 16 | $67 | $4 |
| Clopidogrel | 11 | $54 | $5 |
| Lisinopril | 24 | $52 | $2 |
| Carvedilol | 12 | $42 | $3 |
2016: 7 drugs
| Metoprolol | 15 | $345 | $23 |
| Lisinopril | 19 | $143 | $8 |
| Atorvastatin | 13 | $103 | $8 |
| Pantoprazole | 11 | $102 | $9 |
| Carvedilol | 11 | $44 | $4 |
| Amlodipine Besylate | 12 | $31 | $3 |
| Furosemide | 16 | $29 | $2 |
Professional record
- NPI
- 1043606130
- Licence
- CA A176195California A176195: Current · expires 2028-02-29
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1420 River Park Dr Ste 120, Sacramento, CA, 95815
- NPI first listed
- 2015-04-15
- NPI last updated
- 2022-08-11
- NPI record certified
- 2022-08-11
This is when the NPI record was last certified, not a medical board exam.